Cargando…
Female with bladder cancer: what and why is there a difference?
While men are at a considerable higher risk of developing urothelial carcinoma of the bladder (UCB), women present with more advanced disease stages and seem to experience unfavorable outcomes. Evaluating specific differences in the UCB incidence and outcomes between both genders in the non-muscle i...
Autores principales: | Marks, Phillip, Soave, Armin, Shariat, Shahrokh F., Fajkovic, Harun, Fisch, Margit, Rink, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071204/ https://www.ncbi.nlm.nih.gov/pubmed/27785424 http://dx.doi.org/10.21037/tau.2016.03.22 |
Ejemplares similares
-
Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses?
por: Rink, Michael, et al.
Publicado: (2016) -
Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
por: Janisch, Florian, et al.
Publicado: (2019) -
Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder
por: Vetterlein, Malte W., et al.
Publicado: (2017) -
The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy
por: Rink, Michael, et al.
Publicado: (2020) -
Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study
por: Soave, Armin, et al.
Publicado: (2017)